A Case of Long Term Survival in Patient with Early Intrahepatic Recurrence and Extrahepatic Metastasis after Curative Resection of Hepatocellular Carcinoma.
- Author:
Dong Il JEONG
1
;
Young Mi HONG
;
Mong CHO
;
Ki Tae YOON
Author Information
1. Division of Gastroenterology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea. ktyoon@pusan.ac.kr
- Publication Type:Case Report
- Keywords:
Hepatocellular carcinoma;
Recurrence;
Sorafenib
- MeSH:
Adrenal Glands;
Carcinoma, Hepatocellular*;
Humans;
Liver Neoplasms;
Lung;
Lymph Nodes;
Neoplasm Metastasis*;
Prognosis;
Recurrence*
- From:Journal of Liver Cancer
2015;15(2):132-135
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The most effective therapy in patients with hepatocellular carcinoma (HCC) is curative resection of liver cancer. However, the long-term prognosis is not good in high intrahepatic recurrence. The recurrence rate after curative resection of HCC is 70-100% and the average survival time was about 15.8 months in early relapse after curative resection. Extra hepatic metastases in HCC is associated not uncommon, in general, lungs are the most common organ, lymph nodes, bone, and adrenal gland is relatively often observed. Extrahepatic recurrence after curative resection of HCC has been reported in 14-26% of the total recurrent cancer. Most of the recurrent cancer is multiple and the median survival time of patients after the extrahepatic recurrence is about 4-5 months it found that the prognosis is very poor. Therefore, the authors report a case showed long term survival in patients with early intrahepatic recur and extrahepatic metastasis after curative resection of HCC.
